Table 3.
Effect of Piperonal on plasma glucose, insulin and insulin resistance in normal and experimental obese rats
| Groups | Glucose (mg dl−1) | Insulin (μU ml−1) | Insulin resistance |
|---|---|---|---|
| ND control | 90.9±7.1 | 6.0±0.2 | 3.6±.0.4 |
| HFD Control | 150.1±9.7a* | 27.2±0.4 a* | 6.3±0.2a* |
| HFD + Orlistat 5 mg/kg b.wt | 103.1±4.9 b* | 15.8±1.4 b* | 4.5±0.6 b* |
| HFD + Piperonal 20 mg/kg b.wt | 140.7±7.2 | 24.3.7±0.44 | 6.0±0.2 |
| HFD + Piperonal 30 mg/kg b.wt | 131.7±2.3 b* | 19.7.4±0.5 b* | 5.1±0.2 b* |
| HFD + Piperonal 40 mg/kg b.wt | 101.5±5.5 b* | 17.9±0.24 b* | 4.8±0.3 b* |
Values are mean ± SD, n = 6
Values are statistically significant at * p < 0.05
aSignificantly different from normal control
bSignificantly different from HFD control